A combination of Met@Man-MPs and anti-PD-1 antibodies generated the strongest synergistic anticancer effects with no significant toxicity (Supplementary Fig. 36), resulting in 60% of mice being tumor-free. This evidence concerns the gene PDCD1 and neoplasm.